US equities
|
NVDA
$152.51
▼-1.89%
MU
$701.26
▼-1.57%
AMD
$505.79
▲+0.47%
SPCX
$144.22
▲+1.78%
SNDK
$767.07
▼-3.78%
AAPL
$353.66
▲+0.50%
TSLA
$381.16
▲+0.28%
AMZN
$264.10
▲+2.41%
NVDA
$152.51
▼-1.89%
MU
$701.26
▼-1.57%
AMD
$505.79
▲+0.47%
SPCX
$144.22
▲+1.78%
SNDK
$767.07
▼-3.78%
AAPL
$353.66
▲+0.50%
TSLA
$381.16
▲+0.28%
AMZN
$264.10
▲+2.41%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about schedule I
Recent news which mentions schedule I
DEA Schedules Hearing On Proposed Ban Of Psychedelic Compounds With Therapeutic Potential
August 28, 2024
Tickers
DOC
NEWS
Tags
schedule I
Paul Soeffing
Cannabis
From
Benzinga
DEA Clears This NASDAQ-Traded 'Plant-Touching' Firm To Research And Produce Schedule I And II Plant-Based Drugs
February 23, 2024
Tickers
BGXX
DEA
Tags
research
schedule I
Market News
From
Benzinga